NCT07190846

Brief Summary

This is a prospective observational study conducted at the Maternity and Neonatology Center of Tunis to evaluate cardiac diastolic function in women with preeclampsia compared with normotensive pregnant women. A total of 80 pregnant women in the third trimester were enrolled, including 40 with preeclampsia (mostly severe forms) and 40 healthy controls. All participants underwent standardized transthoracic echocardiography to assess left ventricular diastolic function according to the 2016 ASE/EACVI recommendations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 1, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 24, 2025

Completed
Last Updated

September 24, 2025

Status Verified

September 1, 2025

Enrollment Period

5 months

First QC Date

September 1, 2025

Last Update Submit

September 20, 2025

Conditions

Keywords

Diastolic dysfunctionEchocardiographyMaternal heart functionLeft ventricular relaxationPregnancy hypertensionCardio-obstetricsMaternal cardiovascular risk

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Left Ventricular Diastolic Dysfunction in Preeclamptic Women

    Echocardiographic assessment of diastolic function according to ASE/EACVI 2016 criteria, including parameters E, A, E/A ratio, septal and lateral e' velocities, E/e' ratio, left atrial volume index, and tricuspid regurgitation velocity.

    At baseline, during third-trimester pregnancy hospital evaluation.

Study Arms (2)

Preeclampsia Group

Pregnant women in the third trimester diagnosed with preeclampsia (mostly severe forms), aged 18-45 years, without pre-existing cardiovascular disease or other exclusion criteria.

Other: No Intervention (Observational Echocardiographic Evaluation)

Control Group

Normotensive pregnant women in the third trimester, aged 18-45 years, without cardiovascular disease or other exclusion criteria.

Other: No Intervention (Observational Echocardiographic Evaluation)

Interventions

This is an observational study. No therapeutic intervention is administered. Participants undergo standard echocardiographic assessment of left ventricular diastolic function during pregnancy.

Control GroupPreeclampsia Group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women in the third trimester recruited at the Center of Maternity and Neonatology of Tunis, including 40 with preeclampsia (mainly severe forms) and 40 normotensive controls.

You may qualify if:

  • Pregnant women aged 18-45 years
  • Third trimester of pregnancy
  • Group A: women diagnosed with preeclampsia according to international criteria (blood pressure ≥ 140/90 mmHg after 20 weeks with proteinuria or signs of severity)
  • Group B (controls): normotensive pregnant women without proteinuria or cardiovascular disease
  • Signed informed consent

You may not qualify if:

  • Known pre-existing cardiovascular disease (structural heart disease, heart failure, chronic hypertension complicated)
  • Left ventricular ejection fraction \< 45%
  • Pre-gestational diabetes
  • Chronic kidney disease
  • Multiple pregnancy
  • Other severe comorbidities that could affect cardiac function independently of preeclampsia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maternity and Neonatology Center of Tunis

Tunis, 1007, Tunisia

Location

Related Publications (5)

  • Soma-Pillay P, Louw MC, Adeyemo AO, Makin J, Pattinson RC. Cardiac diastolic function after recovery from pre-eclampsia. Cardiovasc J Afr. 2018 Jan/Feb 23;29(1):26-31. doi: 10.5830/CVJA-2017-031. Epub 2017 Aug 31.

  • Guirguis GF, Aziz MM, Boccia Liang C, Williams SF, Apuzzio JJ, Bilinski R, Mornan AJ, Shah LP. Is preeclampsia an independent predictor of diastolic dysfunction? A retrospective cohort study. Pregnancy Hypertens. 2015 Oct;5(4):359-61. doi: 10.1016/j.preghy.2015.10.001. Epub 2015 Oct 9.

  • Vaught AJ, Kovell LC, Szymanski LM, Mayer SA, Seifert SM, Vaidya D, Murphy JD, Argani C, O'Kelly A, York S, Ouyang P, Mukherjee M, Zakaria S. Acute Cardiac Effects of Severe Pre-Eclampsia. J Am Coll Cardiol. 2018 Jul 3;72(1):1-11. doi: 10.1016/j.jacc.2018.04.048.

  • Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension. 2011 Jan;57(1):85-93. doi: 10.1161/HYPERTENSIONAHA.110.162321. Epub 2010 Nov 22.

  • Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Popescu BA, Waggoner AD. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016 Apr;29(4):277-314. doi: 10.1016/j.echo.2016.01.011. No abstract available.

MeSH Terms

Conditions

Pre-EclampsiaHypertension, Pregnancy-Induced

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Ben marzouk sofiene

    Maternity and Neonatology Center of Tunis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Anesthesiology and Critical Care, Principal Investigator

Study Record Dates

First Submitted

September 1, 2025

First Posted

September 24, 2025

Study Start

March 1, 2025

Primary Completion

July 31, 2025

Study Completion

July 31, 2025

Last Updated

September 24, 2025

Record last verified: 2025-09

Locations